Efficacy and safety of anti-D for immune thrombocytopenic purpura in children

Indian Pediatrics

Volumn 47, Issue 6, 2010, Pages 517-519

  Naithani, Rahul ^a   Kumar, Rajat ^a   Mahapatra, M ^a   Tyagi, Seema ^a   Mishra, Pravas ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Anti D; Children; Immune thrombocytopenic purpura

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY; STEROID; ALLOANTIBODY; RHO(D) ANTIBODY;

ARTICLE; BLEEDING; BLOOD GROUP ABO SYSTEM; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INDIA; MALE; POLYCHROMASIA; PROSPECTIVE STUDY; SCHOOL CHILD; SHEROCYTOSIS; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTE COUNT; TREATMENT RESPONSE; ADOLESCENT; COHORT ANALYSIS; FEVER; PHARMACOKINETICS; PRESCHOOL CHILD; THROMBOCYTOPENIC PURPURA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FEVER; HUMANS; ISOANTIBODIES; MALE; PHARMACOKINETICS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC;

EID: 78049367204     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: 10.1007/s13312-010-0093-3     Document Type: Article

References (15)

1. D.B. Cines V.S. Blanchette 2002 Immune thrombocytopenic purpura N Engl J Med 346 995 1008 10.1056/NEJMra010501 11919310
2. D.M. Arnold J.G. Kelton 2007 Current options for the treatment of idiopathic thrombocytopenic purpura Semin Hematol 44 suppl5 s12 s23 1:CAS:528:DC%2BD1cXhsVCqsr8%3D 10.1053/j.seminhematol.2007.11.003 18096468
3. Rho(D) immune globulin intravenous (Human): WinRho® SDF. Cangene Corporation, Winnipeg, MB, Canada R 3T 5Y3 [professional package insert], October 2004.
4. M.G. Mazzucconi P. Fazi S. Bernasconi G. De Rossi G. Leone L. Gugliotta, et al. 2007 Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience Blood 109 1401 1407 1:CAS:528:DC%2BD2sXjt1CgsrY%3D 10.1182/blood-2005-12-015222 17077333
5. F. Rodeghiero R. Stasi T. Gernsheimer M. Michel D. Proven D.M. Arnold, et al. 2009 Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group Blood 113 2386 2393 1:CAS:528:DC%2BD1MXjsFKhurs%3D 10.1182/blood-2008-07-162503 19005182
6. A. Scradavou B. Woo B.M.R. Woloski Cunningham-Rundles L.J. Ettinger L.M. Aledort, et al. 1997 Intravenous Anti D in treatment of immune thrombocytopenic purpura: experience of 272 patients Blood 89 2689 2700
7. G.C. Newman M.V. Novoa E.M. Fodero M.L. Lesser B.M.R. Woloski J.B. Bussel 2001 A dose of 75 μg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 μg/kg/d in adults with immune thrombocytopenic purpura Br J Haematol 112 1076 1078 1:CAS:528: DC%2BD3MXjsV2qs7Y%3D 10.1046/j.1365-2141.2001.02627.x 11298610
8. M.D. Tarantino G. Young S.J. Bertolone K.A. Kalinyak F.E. Shafer R. Kulkarni, et al. 2006 Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children J Pediatr 148 489 494 1:CAS:528:DC%2BD28XjvVGmtL4%3D 10.1016/j.jpeds.2005.11.019 16647411
9. M.S. El Alfy G.M. Mokhtar M.A. El-Laboudy A.S. Khalifa 2006 Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura Acta Haematol 115 46 52 10.1159/000089465 16424649
10. L. Krishnamurti V.D. Charan N. Desai H. Pati V.P. Choudhry 1994 Anti-D immunoglobulin in the treatment of idiopathic thrombocytopenic purpura Indian J Pediatr 61 179 182 1:STN:280:DyaK2M%2Fht1GgsQ%3D%3D 10.1007/BF02843613 7927616
11. V. Blanchette P. Imbach M. Andrew M. Adams J. McMillan E. Wang, et al. 1994 Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura Lancet 344 703 707 1:STN:280:DyaK2czlvFeisg%3D%3D 10.1016/S0140-6736(94)92205-5 7915773
12. M. Kumar T.A. Vik C.S. Johnson M.E. Southwood J.M. Croop 2005 Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura Am J Hematol 78 181 187 10.1002/ajh.20295 15726607
13. M. Kjaersgaard H. Hasle 2006 A review of Anti D treatment of childhood idiopathic thrombocytopenic purpura Pediatr Blood Cancer 47 717 720 10.1002/pbc.20996 16933265
14. A. Freiberg D. Mauger 1998 Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children Semin Hematol 35 23 27 1:CAS:528: DyaK1cXitVGmuro%3D 9523746
15. A.M. Moser H. Shalev J. Kapelushnik 2002 Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura Pediatr Hematol Oncol 19 407 411 1:CAS:528:DC%2BD38XnvVymsrc%3D 10.1080/08880010290097161 12186363